Imricor Medical Systems, Inc. (ASX:IMR)

Market Cap	613.01M +63.2%
Revenue (ttm)	1.14M -9.2%
Net Income	-54.87M
EPS	-0.20
Shares Out	320.95M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	134,167
Average Volume	323,118
Open	1.980
Previous Close	1.910
Day's Range	1.880 - 1.980
52-Week Range	1.115 - 2.250
Beta	0.28
RSI	56.90
Earnings Date	Feb 25, 2026

About Imricor Medical Systems

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to min...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Country: United States
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IMR

Financial Performance

In 2024, Imricor Medical Systems's revenue was $959,424, an increase of 55.86% compared to the previous year's $615,568. Losses were -$29.69 million, 31.2% more than in 2023.

Financial numbers in USD